Over the last 60 years, the U.S. Food and Drug Administration (FDA) has approved 20 medications for attention deficit/hyperactivity disorder (ADHD). Their approval is based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events. Researchers at Boston Children's Hospital report this in iPLOS ONE/i. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children ...Friday, 11 July 2014
ADHD Drug Approval Shows Gaps Between Approval Process, Long-Term Safety Assessment
Over the last 60 years, the U.S. Food and Drug Administration (FDA) has approved 20 medications for attention deficit/hyperactivity disorder (ADHD). Their approval is based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events. Researchers at Boston Children's Hospital report this in iPLOS ONE/i. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment